Literature DB >> 15422100

Host-parasite relationships in experimental pneumonia due to pneumococcus type III.

W B WOOD, M R SMITH.   

Abstract

Experimental pneumonia was produced with a highly virulent strain of type III pneumococcus which synthesizes, during rapid growth, large amounts of capsular polysaccharide. The type III pneumonia differed from that caused by pneumococcus I in that (a) death occurred more promptly in the type III infection, (b) the local pulmonary lesion became more heavily infected, and (c) frank suppuration was common even after otherwise effective chemotherapy. The greater pathogenicity of the type III organism was shown by special histologic techniques to be due primarily to its capsular slime layer which interferes with surface phagocytosis. Capsular polysaccharide shed from the organism during growth was also demonstrated in high concentration in certain parts of the pneumonic lesion. Removal of the excess polysaccharide from the alveoli resulted from (a) lymphatic drainage to regional lymph nodes and (b) phagocytosis, particularly by macrophages. The possible relationship of the free carbohydrate to the malignancy and the characteristically viscous exudate of type III pneumonia was discussed. The lung abscesses which resulted from type III infection were observed to occur in those areas in which the maximum number of organisms had accumulated. Evidence was obtained that suppuration was due, not to necrotoxic products peculiar to the type III pneumococcus, but rather to the survival of large numbers of bacteria in the tissues, brought about primarily by the antiphagocytic effect of the slime layer. When pneumonia was produced with an intermediate type III mutant lacking the protective slime layer, back mutation to the mucoid parent occurred during the course of the infection, and the mucoid form eventually predominated in the lung as a result of selective phagocytosis of the intermediate organisms. Similar mutation to the maximally virulent type III form was noted with a transformed intermediate type III strain grown from single cell preparations.

Entities:  

Keywords:  PNEUMONIA

Mesh:

Year:  1950        PMID: 15422100      PMCID: PMC2136019          DOI: 10.1084/jem.92.1.85

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  TYPE III PNEUMONIA: THE PROGNOSTIC SIGNIFICANCE OF RETICULATION IN RELATION TO THE NUMBER OF PNEUMOCOCCI IN THE SPUTUM, THERAPY, BACTEREMIA, LEUKOCYTE COUNT, AGE, AND DEGREE OF INVOLVEMENT.

Authors:  A W Frisch; A E Price; G B Myers
Journal:  J Clin Invest       Date:  1943-03       Impact factor: 14.808

2.  The inhibition of surface phagocytosis by the capsular slime layer of pneumococcus type III.

Authors:  W B WOOD; M R SMITH
Journal:  J Exp Med       Date:  1949-07       Impact factor: 14.307

3.  STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : I. THE ACTION OF TYPE SPECIFIC ANTIBODY UPON THE PULMONARY LESION OF EXPERIMENTAL PNEUMONIA.

Authors:  W B Wood
Journal:  J Exp Med       Date:  1941-01-31       Impact factor: 14.307

4.  STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : IV. THE MECHANISM OF PHAGOCYTOSIS IN THE ABSENCE OF ANTIBODY.

Authors:  W B Wood; M R Smith; B Watson
Journal:  J Exp Med       Date:  1946-09-30       Impact factor: 14.307

5.  STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : II. THE EFFECT OF SULFONAMIDE THERAPY UPON THE PULMONARY LESION OF EXPERIMENTAL PNEUMONIA.

Authors:  W B Wood; E N Irons
Journal:  J Exp Med       Date:  1946-09-30       Impact factor: 14.307

6.  THE SPECIFIC POLYSACCHARIDE CONTENT OF PNEUMONIC SPUTA.

Authors:  J T Tripp; A W Frisch; C D Barrett; B E Pidgeon
Journal:  J Exp Med       Date:  1942-12-01       Impact factor: 14.307

7.  STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMONIA DUE TO FRIEDLADER'S BACILLUS : III. THE ROLE OF "SURFACE PHAGOCYTOSIS" IN THE DESTRUCTION OF THE MICROORGANISMS IN THE LUNG.

Authors:  M R Smith; W B Wood
Journal:  J Exp Med       Date:  1947-08-31       Impact factor: 14.307

8.  THE ELABORATION OF SPECIFIC SOLUBLE SUBSTANCE BY PNEUMOCOCCUS DURING GROWTH.

Authors:  A R Dochez; O T Avery
Journal:  J Exp Med       Date:  1917-10-01       Impact factor: 14.307

9.  THE SPECIFIC POLYSACCHARIDES OF TYPES I, II, AND III PNEUMOCOCCUS : A REVISION OF METHODS AND DATA.

Authors:  M Heidelberger; F E Kendall; H W Scherp
Journal:  J Exp Med       Date:  1936-09-30       Impact factor: 14.307

10.  THE SPECIFIC POLYSACCHARIDE CONTENT OF PNEUMONIC LUNGS.

Authors:  A W Frisch; J T Tripp; C D Barrett; B E Pidgeon
Journal:  J Exp Med       Date:  1942-12-01       Impact factor: 14.307

View more
  11 in total

1.  Lung bacterial clearance in murine pneumococcal pneumonia.

Authors:  M J Ansfield; D E Woods; W G Johanson
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

Review 2.  Role of the polymorphonuclear leukocyte: interaction with nosocomial pathogens.

Authors:  G B Toews
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-01       Impact factor: 3.267

3.  Studies on Gonococcus infection. IX. In vitro decreased assocation of pilated gonococci with mouse peritoneal macrophages.

Authors:  M Blake; J Swanson
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

4.  Bacterial exploitation of phosphorylcholine mimicry suppresses inflammation to promote airway infection.

Authors:  Christopher B Hergott; Aoife M Roche; Nikhil A Naidu; Clementina Mesaros; Ian A Blair; Jeffrey N Weiser
Journal:  J Clin Invest       Date:  2015-08-31       Impact factor: 14.808

5.  Experimental type 25 pneumococcal pneumonia in rats: an electron-microscopic study.

Authors:  K Yoneda; J D Coonrod
Journal:  Am J Pathol       Date:  1980-04       Impact factor: 4.307

6.  Type 3 diplococcus pneumonia in laboratory rats.

Authors:  H Baer; A Preiser
Journal:  Can J Comp Med       Date:  1969-04

7.  Antiphagocytic Effect of Slime from a Mucoid Strain of Pseudomonas aeruginosa.

Authors:  S Schwarzmann; J R Boring
Journal:  Infect Immun       Date:  1971-06       Impact factor: 3.441

8.  Efficacy of antimicrobial therapy in experimental rat pneumonia: effects of impaired phagocytosis.

Authors:  I A Bakker-Woudenberg; J Y de Jong-Hoenderop; M F Michel
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

Review 9.  Nosocomial pneumonia.

Authors:  Waldemar G Johanson; Lisa L Dever
Journal:  Intensive Care Med       Date:  2002-12-04       Impact factor: 17.440

10.  An experimental analysis of the curative action of penicillin in acute bacterial infections. I. The relationship of bacterial growth rates to the antimicrobial effect of penicillin.

Authors:  W B WOOD; M R SMITH
Journal:  J Exp Med       Date:  1956-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.